Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 3:30 pm Purchase | 2025-10-30 | 13D | NEWCELX LTD SHS NCEL | Michel Revel | 940,787 20.200% | 940,787 (New Position) | Filing History |
| 2025-11-13 2:12 pm Purchase | 2025-10-30 | 13D | NEWCELX LTD SHS NCEL | Ronen Twito | 272,399 6.000% | 272,399 (New Position) | Filing History |
| 2025-11-13 08:59 am Purchase | 2025-10-30 | 13G | NEWCELX LTD SHS NCEL | League Jinn Sarl | 988,996 21.600% | 988,996 (New Position) | Filing History |
| 2025-11-07 9:41 pm Purchase | 2025-10-30 | 13G | NEWCELX LTD SHS NCEL | Clover Wolf Capital - Limited Partnership | 343,120 7.500% | 343,120 (New Position) | Filing History |
| 2025-11-04 6:57 pm Purchase | 2025-10-31 | 13G | NEWCELX LTD SHS NCEL | BIOTECHNOLOGY VALUE FUND L P | 28,732 0.600% | 28,732 (New Position) | Filing History |
| 2025-06-24 4:57 pm Purchase | 2025-05-22 | 13D | NLS Pharmaceutics AG NLSP | Ronald Hafner | 55,713 13.200% | 24,617 (+79.17%) | Filing History |
| 2025-02-14 5:08 pm Sale | 2024-12-31 | 13G | NLS Pharmaceutics AG NLSP | Lind Global Fund II LP | 5,978 4.900% | -4,375 (-42.26%) | Filing History |
| 2024-11-21 4:01 pm Purchase | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | Ronald Hafner | 31,096 8.100% | 31,096 (New Position) | Filing History |
| 2024-11-14 7:27 pm Purchase | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | Lind Global Fund II LP | 10,353 8.100% | 10,353 (New Position) | Filing History |
| 2024-11-14 3:33 pm Purchase | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | Armistice Capital, LLC | 12,948 9.990% | 12,948 (New Position) | Filing History |
| 2024-11-04 7:39 pm Sale | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | YA II PN, Ltd. | 0 0.000% | -9,898 (Position Closed) | Filing History |
| 2024-11-04 6:20 pm Purchase | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | Grisard Felix | 10,737 2.800% | 2,629 (+32.43%) | Filing History |
| 2024-10-15 1:24 pm Purchase | 2024-10-10 | 13G | NLS Pharmaceutics AG NLSP | Alpha Capital Anstalt | 24,700 9.990% | 24,700 (New Position) | Filing History |
| 2024-03-27 7:37 pm Purchase | 2024-03-22 | 13G | NLS Pharmaceutics AG NLSP | Lind Global Fund II LP | 10,750 9.900% | 10,750 (New Position) | Filing History |
| 2024-02-12 4:37 pm Purchase | 2023-12-31 | 13G | NLS Pharmaceutics AG NLSP | YA II PN, Ltd. | 9,898 9.990% | 2,280 (+29.93%) | Filing History |
| 2023-02-24 07:55 am Purchase | 2022-10-02 | 13G | NLS Pharmaceutics AG NLSP | Grisard Felix | 8,107 9.990% | 8,107 (New Position) | Filing History |
| 2023-02-14 4:32 pm Sale | 2022-12-31 | 13G | NLS Pharmaceutics AG NLSP | Magnetic Rock Investment AG | 7,113 8.770% | -1,025 (-12.60%) | Filing History |
| 2023-02-13 7:32 pm Purchase | 2022-12-31 | 13G | NLS Pharmaceutics AG NLSP | Konofal Eric | 2,563 3.200% | 13 (+0.49%) | Filing History |
| 2023-02-13 4:02 pm Purchase | 2022-12-31 | 13G | NLS Pharmaceutics AG NLSP | Zwyer Alexander | 3,135 3.900% | 135 (+4.50%) | Filing History |
| 2023-01-03 3:58 pm Purchase | 2022-12-31 | 13G | NLS Pharmaceutics AG NLSP | YA II PN, Ltd. | 7,618 9.990% | 3,603 (+89.75%) | Filing History |